Hudson Bay Capital Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.75M | Sell |
77,593
-72,787
| -48% | -$9.15M | 0.03% | 258 |
|
|
2025
Q1 | $16.6M | Buy |
150,380
+120,038
| +396% | +$13.3M | 0.05% | 168 |
|
|
2024
Q4 | $4.14M | Sell |
30,342
-9,658
| -24% | -$1.32M | 0.01% | 389 |
|
|
2024
Q3 | $4.61M | Sell |
40,000
-5,000
| -11% | -$576K | 0.02% | 310 |
|
|
2024
Q2 | $6.2M | Buy |
45,000
+15,000
| +50% | +$2.07M | 0.03% | 268 |
|
|
2024
Q1 | $4.14M | Sell |
30,000
-27,500
| -48% | -$3.79M | 0.02% | 286 |
|
|
2023
Q4 | $7.58M | Buy |
57,500
+7,500
| +15% | +$988K | 0.05% | 194 |
|
|
2023
Q3 | $5.63M | Sell |
50,000
-27,500
| -35% | -$3.09M | 0.04% | 218 |
|
|
2023
Q2 | $7.31M | Buy |
77,500
+47,500
| +158% | +$4.48M | 0.05% | 187 |
|
|
2023
Q1 | $3.04M | Buy |
30,000
+19,160
| +177% | +$1.94M | 0.03% | 397 |
|
|
2022
Q4 | $1.29M | Sell |
10,840
-94,160
| -90% | -$11.2M | 0.01% | 627 |
|
|
2022
Q3 | $11.2M | Sell |
105,000
-65,000
| -38% | -$6.9M | 0.1% | 124 |
|
|
2022
Q2 | $16.6M | Buy |
170,000
+15,000
| +10% | +$1.46M | 0.13% | 77 |
|
|
2022
Q1 | $14.5M | Buy |
155,000
+20,000
| +15% | +$1.87M | 0.2% | 72 |
|
|
2021
Q4 | $11.5M | Buy |
135,000
+55,111
| +69% | +$4.69M | 0.12% | 99 |
|
|
2021
Q3 | $7.66M | Buy |
79,889
+9,889
| +14% | +$948K | 0.1% | 197 |
|
|
2021
Q2 | $6.81M | Buy |
70,000
+5,000
| +8% | +$487K | 0.08% | 227 |
|
|
2021
Q1 | $6.32M | Sell |
65,000
-5,000
| -7% | -$486K | 0.08% | 212 |
|
|
2020
Q4 | $6.71M | Buy |
70,000
+40,000
| +133% | +$3.83M | 0.07% | 173 |
|
|
2020
Q3 | $2.89M | Buy |
+30,000
| New | +$2.89M | 0.04% | 294 |
|
|
2020
Q2 | – | Sell |
-10,000
| Closed | -$866K | – | 523 |
|
|
2020
Q1 | $866K | Buy |
+10,000
| New | +$866K | 0.02% | 332 |
|
|
2019
Q3 | – | Sell |
-30,000
| Closed | -$2.53M | – | 428 |
|
|
2019
Q2 | $2.53M | Buy |
30,000
+25,000
| +500% | +$2.11M | 0.06% | 220 |
|
|
2019
Q1 | $441K | Buy |
+5,000
| New | +$441K | 0.01% | 370 |
|